Key points are not available for this paper at this time.
Pyrotinib showed promising antitumor activity and an acceptable safety profile in chemotherapy-treated patients with HER2-mutant NSCLC.
Building similarity graph...
Analyzing shared references across papers
Loading...
Caicun Zhou
Xingya Li
Qiming Wang
Journal of Clinical Oncology
Peking University
Central South University
Tongji University
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhou et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d73a94b54ccf0cfef3094a — DOI: https://doi.org/10.1200/jco.20.00297